serw-MX  [xml]  
 
    
 DeCS Categories

D27 Chemical Actions and Uses .
D27.505 Pharmacologic Actions .
D27.505.519 Molecular Mechanisms of Pharmacological Action .
D27.505.519.186 Antimetabolites .
D27.505.519.186.071 Hypolipidemic Agents .
D27.505.519.186.071.202 Anticholesteremic Agents .
D27.505.519.389 Enzyme Inhibitors .
D27.505.519.389.275 Cholinesterase Inhibitors .
D27.505.519.625 Neurotransmitter Agents .
D27.505.519.625.120 Cholinergic Agents .
D27.505.519.625.120.200 Cholinergic Antagonists .
D27.505.519.625.120.300 Cholinesterase Inhibitors .
D27.505.696 Physiological Effects of Drugs .
D27.505.696.577 Neurotransmitter Agents .
D27.505.696.577.120 Cholinergic Agents .
D27.505.696.577.120.200 Cholinergic Antagonists .
D27.505.696.577.120.300 Cholinesterase Inhibitors .
D27.505.954 Therapeutic Uses .
D27.505.954.557 Lipid Regulating Agents .
D27.505.954.557.500 Hypolipidemic Agents .
D27.505.954.557.500.202 Anticholesteremic Agents .
 
 Terms
 Synonyms & Historicals		Documents
LILACS e MDL		 
Anticholesteremic Agents .
Anticholesteremic Drugs .
Anticholesteremics .
Inhibitors, Cholesterol .
Agents, Anticholesteremic .
Agents, Hypocholesteremic .
Drugs, Anticholesteremic .
Hypocholesteremic Agents .
Cholesterol Inhibitors .
Substances used to lower plasma CHOLESTEROL levels. .
1.00
 
Cholinesterase Inhibitors .
Anti-Cholinesterases .
Anticholinesterase Drugs .
Anticholinesterases .
Cholinesterase Inhibitors, Irreversible .
Cholinesterase Inhibitors, Reversible .
Agents, Anticholinesterase .
Anti Cholinesterases .
Drugs, Anticholinesterase .
Inhibitors, Acetylcholinesterase .
Inhibitors, Cholinesterase .
Inhibitors, Irreversible Cholinesterase .
Inhibitors, Reversible Cholinesterase .
Irreversible Cholinesterase Inhibitors .
Reversible Cholinesterase Inhibitors .
Acetylcholinesterase Inhibitors .
Anticholinesterase Agents .
Drugs that inhibit cholinesterases. The neurotransmitter ACETYLCHOLINE is rapidly hydrolyzed, and thereby inactivated, by cholinesterases. When cholinesterases are inhibited, the action of endogenously released acetylcholine at cholinergic synapses is potentiated. Cholinesterase inhibitors are widely used clinically for their potentiation of cholinergic inputs to the gastrointestinal tract and urinary bladder, the eye, and skeletal muscles; they are also used for their effects on the heart and the central nervous system. .
0.75
 
Cholinergic Antagonists .
Anti-Cholinergics .
Anticholinergics .
Cholinergic Antagonist .
Cholinergic Receptor Antagonists .
Agents, Anticholinergic .
Agents, Cholinergic-Blocking .
Antagonist, Cholinergic .
Antagonists, Acetylcholine .
Antagonists, Cholinergic .
Antagonists, Cholinergic Receptor .
Anti Cholinergics .
Cholinergic Blocking Agents .
Receptor Antagonists, Cholinergic .
Acetylcholine Antagonists .
Anticholinergic Agents .
Cholinergic-Blocking Agents .
Cholinolytics .
Drugs that bind to but do not activate CHOLINERGIC RECEPTORS, thereby blocking the actions of ACETYLCHOLINE or cholinergic agonists. .
0.67